GRCL
Gracell Biotechnologies Inc.
NASDAQ: GRCL · HEALTHCARE · BIOTECHNOLOGY
$10.25
+0.00% today
Updated 2026-04-30
Market cap
$989.87M
P/E ratio
—
P/S ratio
732.21x
EPS (TTM)
$-0.97
Dividend yield
—
52W range
$307 – $525
Volume
6.4M
Gracell Biotechnologies Inc. (GRCL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |